Observational studyJournal of diabetes research2022

Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.

Yuki Oe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.